CURIS, INC. Proceeds from Stock Options Exercised
CURIS, INC. (CRIS) reported Proceeds from Stock Options Exercised of $375.66 thousand for the 3-month period ending 2012-12-31, per its 10-K filed 2013-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2013-11-12
- CURIS, INC. proceeds from stock options exercised for the quarter ending 2012-12-31 was $375.66K.
- CURIS, INC. proceeds from stock options exercised for the quarter ending 2012-09-30 was $0.00.
- CURIS, INC. proceeds from stock options exercised for the quarter ending 2012-06-30 was $0.00.
- CURIS, INC. proceeds from stock options exercised for the quarter ending 2012-03-31 was $375.66K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2012-12-31 | $375.66K 10-K · filed 2013-03-13 | $375.66K derived: sum of 2 quarters · filed 2013-11-12 | $375.66K derived: sum of 3 quarters · filed 2013-11-12 | $751.32K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $375.66K 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $375.66K 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $375.66K 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |